Bausch Health Files 8-K on Shareholder Votes
Ticker: BHC · Form: 8-K · Filed: May 14, 2025 · CIK: 885590
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
TL;DR
Bausch Health filed an 8-K for shareholder votes. Standard procedure.
AI Summary
Bausch Health Companies Inc. filed an 8-K on May 14, 2025, to report on matters submitted to a vote of its security holders. The filing details the submission of various proposals for shareholder approval, as is standard for companies holding shareholder meetings.
Why It Matters
This filing indicates that Bausch Health is engaging with its shareholders on important corporate matters, which could include executive compensation, board elections, or other significant corporate actions.
Risk Assessment
Risk Level: low — This is a routine filing reporting on matters submitted to a vote of security holders, with no immediate financial or operational impact indicated.
Key Players & Entities
- Bausch Health Companies Inc. (company) — Registrant
- Valeant Pharmaceuticals International, Inc. (company) — Former Company Name
- BIOVAIL Corp (company) — Former Company Name
- BIOVAIL CORP INTERNATIONAL (company) — Former Company Name
FAQ
What specific matters were submitted for a vote of Bausch Health's security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the provided text excerpt.
When was this 8-K filing submitted?
The filing was submitted on May 14, 2025.
What is Bausch Health Companies Inc.'s principal executive office address?
The principal executive offices are located at 2150 St. Elzéar Blvd. West, Laval, Québec, Canada H7L 4A8.
What is Bausch Health's telephone number?
The registrant's telephone number is (514) 744-6792.
What is Bausch Health's IRS Employer Identification Number?
The IRS Employer Identification Number is 98-0448205.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding Bausch Health Companies Inc. (BHC).